<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>90</volume><submitter>Rada P</submitter><funding>Center for Networked Biomedical Research on Neurodegenerative Diseases</funding><funding>Carlos III Health Institute</funding><funding>Ministerio de Ciencia e Innovación</funding><funding>Biomedical Research Network Centre of Diabetes and Associated Metabolic Diseases</funding><funding>Community of Madrid</funding><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Protein kinase D (PKD) family is emerging as relevant regulator of metabolic homeostasis. However, the precise role of PKD2 in modulating hepatic insulin signaling has not been fully elucidated and it is the aim of this study.&lt;h4>Methods&lt;/h4>PKD inhibition was analyzed for insulin signaling in mouse and human hepatocytes. PKD2 was overexpressed in Huh7 hepatocytes and mouse liver, and insulin responses were evaluated. Mice with hepatocyte-specific PKD2 depletion (PKD2&lt;sup>ΔHep&lt;/sup>) and PKD2&lt;sup>fl/fl&lt;/sup> mice were fed a chow (CHD) or high fat diet (HFD) and glucose homeostasis and lipid metabolism were investigated.&lt;h4>Results&lt;/h4>PKD2 silencing enhanced insulin signaling in hepatocytes, an effect also found in primary hepatocytes from PKD2&lt;sup>ΔHep&lt;/sup> mice. Conve</pubmed_abstract><journal>Molecular metabolism</journal><pagination>102045</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11535753</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Protein kinase D2 modulates hepatic insulin sensitivity in male mice.</pubmed_title><pmcid>PMC11535753</pmcid><pubmed_authors>Sabio G</pubmed_authors><pubmed_authors>Carceller-Lopez E</pubmed_authors><pubmed_authors>Fernandez-Hernandez C</pubmed_authors><pubmed_authors>Hitos AB</pubmed_authors><pubmed_authors>Gomez-Santos B</pubmed_authors><pubmed_authors>Aspichueta P</pubmed_authors><pubmed_authors>Rada P</pubmed_authors><pubmed_authors>Pose-Utrilla J</pubmed_authors><pubmed_authors>Iglesias T</pubmed_authors><pubmed_authors>Valverde AM</pubmed_authors><pubmed_authors>Rey E</pubmed_authors><pubmed_authors>Garcia A</pubmed_authors><pubmed_authors>Gonzalez-Rodriguez A</pubmed_authors><pubmed_authors>Garcia-Monzon C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protein kinase D2 modulates hepatic insulin sensitivity in male mice.</name><description>&lt;h4>Objectives&lt;/h4>Protein kinase D (PKD) family is emerging as relevant regulator of metabolic homeostasis. However, the precise role of PKD2 in modulating hepatic insulin signaling has not been fully elucidated and it is the aim of this study.&lt;h4>Methods&lt;/h4>PKD inhibition was analyzed for insulin signaling in mouse and human hepatocytes. PKD2 was overexpressed in Huh7 hepatocytes and mouse liver, and insulin responses were evaluated. Mice with hepatocyte-specific PKD2 depletion (PKD2&lt;sup>ΔHep&lt;/sup>) and PKD2&lt;sup>fl/fl&lt;/sup> mice were fed a chow (CHD) or high fat diet (HFD) and glucose homeostasis and lipid metabolism were investigated.&lt;h4>Results&lt;/h4>PKD2 silencing enhanced insulin signaling in hepatocytes, an effect also found in primary hepatocytes from PKD2&lt;sup>ΔHep&lt;/sup> mice. Conve</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-07-16T13:19:54.785Z</modification><creation>2025-04-04T18:54:24.628Z</creation></dates><accession>S-EPMC11535753</accession><cross_references><pubmed>39401614</pubmed><doi>10.1016/j.molmet.2024.102045</doi></cross_references></HashMap>